1)somatostatin analogue生长抑素类似物
1.Mechanism of central inhibition of gastric acid secretion in rats by the somatostatin analogue octreotide;生长抑素类似物奥曲肽中枢抑制大鼠胃酸分泌的机制
2.The regulative effect of somatostatin analogue on growth of human gastric cancer cell line MKN45;生长抑素类似物对胃癌细胞株MKN45生长的调控作用
3.Recent development of radio-labeled somatostatin analogues as receptor image agent;生长抑素类似物及其标记核素
英文短句/例句
1.Growth Inhibition Effect of Somatostatin Anologue Octreotide on Cholangiocarcinoma Cell;生长抑素类似物抑制胆管癌细胞增殖的研究
2.The Ragulatory Effect of Somatostatin on the Growth of Gastric Carcinoma Cell Line;生长抑素类似物对人胃癌细胞生长的调控作用
3.Combined Somatostatin Receptor Ⅱ Gene with Somatostatin Analogue Inhibit Growth of Human Pancreatic Cancinoma;生长抑素类似物基因治疗胰腺癌的试验研究
4.Application of somatostatin analogues in treatment of acute obstructive ileus生长抑素类似物在急性机械性肠梗阻中的应用
5.Experimental study on synthesizing and appraising depreotide生长抑素类似物depreotide的合成与鉴定的实验研究
6.Inhibition of Proliferation by Somatostatin Analogs in Two Kinds of Lung Cancer Cell Lines生长抑素类似物对两种肺癌细胞株增殖的抑制作用
7.Inhibitory Effects of Octreotide on the Growth of Gastric Cancer in Vivo;生长抑素类似物对人胃癌裸鼠种植瘤生长增殖的影响
8.Investigation of Somatostatin Analogue Octreotide's Effect on the Experimental Choroidal Neovascularization;生长抑素类似物奥曲肽对实验性脉络膜新生血管的治疗研究
9.Studies on Apoptosis and Bcl-2/Bax Gene Expression Induced by Somatostatin Analogue in Human Hepatoma Cell Line Hepg_2;生长抑素类似物诱导肝癌细胞凋亡和bcl-2/bax表达的研究
10.Studies of Somatostatin Analogues and Multidrug Resistance Reversethe in Gastric Carcinoma;生长抑素类似物和胃癌多药耐药逆转的实验研究
11.Inhibitory Effects of Octreotide on the Incursions and Metastasis of Gastric Cancer in Vivo;生长抑素类似物对人胃癌裸鼠种植瘤侵袭转移的影响
12.Investigations on Binding Characteristics of Two Newly Design Somatostatin Analogues to Three Opioid Receptors;两种新型生长抑素类似物与阿片受体结合作用探讨
13.The Effects of Somatostatin Analog Octreotide on the Proliferation in Human Umbilical Vein Endothelial Cells;生长抑素类似物奥曲肽对人脐静脉内皮细胞增殖影响的实验研究
14.The Effect of Somatostatin Analogue in the Treatment of Non-variceal Upper Gastrointestinal Bleeding;生长抑素类似物在非静脉曲张性上消化道出血中的治疗应用
15.Effect of octreotide on cell proliferation in pancreatic adenocarcinoma生长抑素类似物奥曲肽对胰腺癌细胞增殖的影响
16.The Effects of Somatostatin Analogue Octreotide on the Proliferation in Human Cholangiocarcinoma Cells in Vitro and Its Probable Mechanisms;生长抑素类似物奥曲肽抑制体外培养人胆管癌细胞生长及其可能机制的实验研究
17.An Experimental Study of Prevention Effect of the Somatostatin Analogue (Octreotide) on the Growth and Trans-portal Vein Metastasis of the Mice Bearing Hepatocellular Carcinoma;生长抑素类似物奥曲肽对小鼠原位移植性肝癌和门脉转移性肝癌的抑制作用的实验研究
18.Experimental Study of the Effect of Somatostatin Analog Octreotide on the Expression and Production of VEGF in Human Hepatocellular Carcinoma Cells;生长抑素类似物奥曲肽对人肝癌细胞血管内皮生长因子表达与合成影响的实验研究
相关短句/例句
Somatostatin analogues生长抑素类似物
1.The role of radionuclide-labeled somatostatin analogues in lymphoma;放射性核素标记生长抑素类似物在淋巴瘤中的应用
2.A Meta-analysis of somatostatin analogues in treatment of Graves ophthalmopathy;生长抑素类似物对Graves眼病治疗作用的Meta分析
3.Newly developed somatostatin analogues,such as some long-acting somatostatin analogues and a synthetic SOM230,have been developed and they have small side effects and good tolerance are well tolerated in the patients with TAO.近年来发现新的生长抑素类似物,如长效生长抑素类似物和合成的SOM230等,患者耐受性好,越来越广泛的应用于评价和治疗甲状腺相关眼病。
3)Somatostatin analog生长抑素类似物
4)long-acting somatostatin anologues长效生长抑素类似物
5)Somatostatin[英][s?um?t?u'st?tin][美][so,m?t?'st?tn, ,som?t?-]生长抑素及其类似物
1.Somatostatin and its analog.心得安推荐作为预防Child A或B级肝硬化患者中-重度静脉曲张初次出血;生长抑素及其类似物为急性食管胃底静脉曲张出血(EVB)的首选药物,控制出血疗效85%-90%;心得安或联合5-单硝异山梨醇、内镜下套扎或硬化剂可作为预防静脉曲张再出血的方法;经颈静脉肝内门腔分流术(TIPS)仅为Child B或C级患者准备肝脏移植的过度。
6)somatostatin/analogs & derivatives生长抑素/类似物和衍生物
延伸阅读
生长抑素分子式：CAS号：性质：即生长激素释放抑制激素。除分布在下丘脑中外，此外脑中枢神经系统、弥散神经系统中也有分泌，不仅存在于细胞体中，而且也存在于中枢神经的神经纤维中。有些内分泌细胞的周围组织中也有存在，如胰岛的小细胞、肠胃道的黏膜内分泌细胞、人甲状腺和胎盘中；鼠的胸腺、输卵管、卵巢及唾液腺中，甚至许多肿瘤中也有发现。下丘脑中分离出来的SRIH是一种环状14肽，其氨基酸序列为：现在人工合成了一组8肽衍生物，结构为：可替代14肽，且活性、稳定性更好，还可用于检测与治疗肿瘤。近来年从猪小肠上段酸性提取物中分离出一种具有SRIH样免疫活性的肽，它比14肽大，其N一端延伸部分可能是一个7肽：Ser—Ala—Ala—Arg—Asn—Gln—Arg。胃肠道有一种SRIH前体为28肽，称为SRIH-28。SRIH-28是一种强的胰岛素分泌抑制剂，其效价比SRIH-14强380倍。SRIH合成的主要部位是胰腺和胃肠道。胃肠道占总量的70%，脑占25%，胰腺占5%。SRIH具有广泛的抑制作用，还可减少内脏血流量，有亲神经作用。是一种广谱型抑制型调节因子。
